课题基金 / 基金详情

Telomerase-specific fluorescent navigation system for lung cancer surgery

Telomerase-specific fluorescent navigation system for lung cancer surgery
用于肺癌手术的端粒酶特异性荧光导航系统
批准号:
17390381
负责人:
FUJIWARA Toshiyoshi
金额:
$9.86万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

FUJIWARA Toshiyoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Currently available methods for detection of tumors in vivo such as X-ray, computed tomography, and ultrasonography are noninvasive and well studied; the images, however, are not specific for tumors. Direct optical imaging of tumor cells in vivo that can clearly distinguish them from surrounding normal tissues may be clinically useful. Here, we describe a new approach to visualizing tumors whose fluorescence can be detected using telomerase-specific replication-competent adenovirus expressing green fluorescent protein (GFP) (OBP-401). OBP-401 contains the replication cassette, in which the human telomerase reverse transcriptase (hTERT) promoter drives expression of El genes, and the GFP gene for monitoring viral replication. The hTERT is the catalytic subunit of telomerase, which is highly active in cancer cells, but is quiescent in most normal somatic cells. When the human lung cancer cell line H1299 was infected with OBP-401, the virus replicated in tumor cells and showed strong green signals. In contrast, infection of OBP-401 did not show any signals in normal cells such as fibroblasts. We also found that established subcutaneous tumors could be visualized following intratumoral injection of OBP-401. H1299 human lung tumors transplanted into BALB/c nu/nu mice were intratumorally injected with 1 x 10^8 plaque forming units (PFU) of OBP-401. Within 24 hours of treatment, the fluorescence of the expressed GFP became visible by 3CCD camera in these tumors. Moreover, intrathoracic administration of OBP-401 could visualize disseminated A549 tumor nodules in mice following intrathoracic implantation. Our results indicate that intratumoral or intrathoracic injection of OBP-401 might be a useful diagnostic method that provides a foundation for future clinical application.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1002/ijc.21846
发表时间: 2006-07-15
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Fujiwara, Toshiya, Kagawa, Shunsuke, Fujiwara, Toshiyoshi]
通讯作者: Fujiwara, Toshiyoshi
悪性腫瘍に対するウイルス製剤Telomelysinの臨床開発.
用于恶性肿瘤的病毒药物 Telomelysin 的临床开发。
DOI: --
发表时间: 2006
期刊: Biotherapy 20
影响因子: --
作者: [Watanabe, T., 藤原俊義]
通讯作者: 藤原俊義
DOI: 10.1038/nm1404
发表时间: 2006-10-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者: [Kishimoto, Hiroyuki, Kojima, Toru, Fujiwara, Toshiyoshi]
通讯作者: Fujiwara, Toshiyoshi
DOI: 10.1038/sj.onc.1208460
发表时间: 2005-04-28
期刊: ONCOGENE
影响因子: 8
作者: [Taki, M, Kagawa, S, Fujiwara, T]
通讯作者: Fujiwara, T
Development of the Dual fluorescent cytology with tumor-specific viruses for gastrointestinal cancer precision medicine
  • 批准号:
    16H05416
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.32万
  • 财政年份:
    2016
  • 负责人:
    FUJIWARA Toshiyoshi
  • 依托单位:
Fluorescent virus-guided capturing of epithelial-mesenchymal transition (EMT)-induced circulating tumor cells (CTCs) for genetic analysis
  • 批准号:
    25670580
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2013
  • 负责人:
    FUJIWARA Toshiyoshi
  • 依托单位:
"Cell-in-cell" activity-based tumor-specific delivery of biologics
  • 批准号:
    25293283
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.73万
  • 财政年份:
    2013
  • 负责人:
    FUJIWARA Toshiyoshi
  • 依托单位:
Molecular therapy for gastric cancer using HER2-extracellular domain-expressing adenovirus
  • 批准号:
    22390256
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.4万
  • 财政年份:
    2010
  • 负责人:
    FUJIWARA Toshiyoshi
  • 依托单位:
海外基金